Home / Ketorolac / United States
US ATC M01AB15 · updated 2 Nov 2026
Ketorolac shortage in United States
Is there a Ketorolac shortage in United States?
Yes. As of 2 Nov 2026, 26 Ketorolac products are reported short in United States, the first since 23 Mar 2018. No return date has been given. Main reason: not stated.
Also short in Canada, Switzerland, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | Gland Pharma Limited | 23 Mar 2018 | not given | Not stated |
| US | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25) | Alembic Pharmaceuticals | 23 Mar 2018 | not given | Not stated |
| US | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Not stated |
| US | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Other |
| US | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Gland Pharma Limited | 23 Mar 2018 | not given | Not stated |
| US | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Gland Pharma Limited | 23 Mar 2018 | not given | Not stated |
| US | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25) | Alembic Pharmaceuticals | 23 Mar 2018 | not given | Not stated |
| US | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| US | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| US | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Other |
| US | Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25) | Alembic Pharmaceuticals | 23 Mar 2018 | not given | Not stated |
| US | Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20) | Fresenius Kabi USA, LLC | 23 Mar 2018 | not given | Other |
| US | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01) | Hospira, Inc., a Pfizer Company | 26 Mar 2018 | not given | Other |
| US | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) limited | Sagent Pharmaceuticals | 26 Mar 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| US | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) | Hospira, Inc., a Pfizer Company | 26 Mar 2018 | not given | Other |
| US | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Sagent Pharmaceuticals | 26 Mar 2018 | not given | Not stated |
| US | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Sagent Pharmaceuticals | 26 Mar 2018 | not given | Not stated |
| US | Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01) | Hospira, Inc., a Pfizer Company | 26 Mar 2018 | not given | Other |
| US | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) | Baxter Healthcare | 6 Jun 2018 | not given | Increased demand Demand increase for the drug |
| US | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25) | Hikma Pharmaceuticals USA, Inc. | 6 Jun 2018 | not given | Other |
| US | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) | Baxter Healthcare | 6 Jun 2018 | not given | Not stated |
| US | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25) | Hikma Pharmaceuticals USA, Inc. | 6 Jun 2018 | not given | Other |
| US | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25) | Hikma Pharmaceuticals USA, Inc. | 6 Jun 2018 | not given | Other |
| US | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25) | Gland Pharma Limited | 6 Jun 2018 | not given | Not stated |
| US | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25) | Gland Pharma Limited | 6 Jun 2018 | not given | Not stated |
| US | Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01) discontinuation | Mylan Pharmaceuticals Inc., a Viatris Company | 20 Apr 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).